financetom
Business
financetom
/
Business
/
Qiagen Reports Over 1,000 Placements of EZ2 Connect Instrument Globally
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Qiagen Reports Over 1,000 Placements of EZ2 Connect Instrument Globally
Dec 5, 2024 3:00 PM

05:37 PM EST, 12/05/2024 (MT Newswires) -- Qiagen ( QGEN ) said late Thursday that more than 1,000 EZ2 Connect instruments have been placed globally since the machine was launched in 2021.

The instrument automates the nucleic acid purification process and is mainly used in molecular biology research applications and laboratory tests.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CGI Launching 'Human-centric' AI Platform SpeedOps
CGI Launching 'Human-centric' AI Platform SpeedOps
Jul 28, 2025
08:21 AM EDT, 07/28/2025 (MT Newswires) -- CGI (GIB-A.TO and NYSE: GIB), one of the largest independent IT and business consulting services firms in the world, on Monday launched CGI SpeedOps, that harnesses AI, cloud, automation, and data-driven insights for clients across commercial and public sector industries. ...
Alterity Therapeutics Says ATH434 Conferred Clinical Benefit in Phase 2 Trial for Multiple System Atrophy
Alterity Therapeutics Says ATH434 Conferred Clinical Benefit in Phase 2 Trial for Multiple System Atrophy
Jul 28, 2025
08:21 AM EDT, 07/28/2025 (MT Newswires) -- Alterity Therapeutics ( ATHE ) said Monday that phase 2 data for ATH434 in patients with multiple system atrophy showed that the oral agent conferred a clinical benefit on areas of impairment in MSA and stabilized key biomarkers. Results from the trial showed that ATH434 reduced disease progression by about 50% compared with...
Adaptimmune to Sell Cell Therapy Programs to US WorldMeds for Up to $85 Million
Adaptimmune to Sell Cell Therapy Programs to US WorldMeds for Up to $85 Million
Jul 28, 2025
08:20 AM EDT, 07/28/2025 (MT Newswires) -- Adaptimmune Therapeutics ( ADAP ) said Monday it has agreed to sell its cell therapy programs, Tecelra, lete-cel, afami-cel, and uza-cel to US WorldMeds for $55 million in cash upfront, with potential milestone payments of up to $30 million. The company said the deal includes all related intellectual property necessary to manufacture and...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved